Last reviewed · How we verify

NCT02774083: Feuerstein

Cognitive Training Using Feuerstein Instrumental Enrichment

Completed NA Last updated 24 September 2019
What this trial tests

NA trial testing Feuerstein Program in Mild Cognitive Impairment in 26 participants. Completed in 31 May 2016.

Timeline
3 September 2015
Primary endpoint
31 May 2016
31 May 2016

Quick facts

Lead sponsorRambam Health Care Campus
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment26
Start date3 September 2015
Primary completion31 May 2016
Estimated completion31 May 2016
Sites5 locations across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Rambam Health Care Campus — full company profile →

Who can join

60 and older, any sex, with Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: The Feuerstein Instrumental Enrichment Program was designed to prevent mental deterioration and preserve cognitive abilities among people aged 60 and above. The program is an applied practicable program based on the theories of Structural Cognitive Modifiability as well as on a Mediated Learning Experience. The program takes into consideration the unique characteristics and requirements of the older population. The program is composed of a variety of cognitive tasks that offer systematic activities intended to stimulate mental and cognitive development. Objective: To examine the influence of the Feuerstein Program on the cognitive function and well-being of participants suffering from Mild Cognitive Impairment (MCI). Hypothesis: The Feuerstein Program will improve cognitive abilities and functional well-being of the participants. Methods: Residents of retirement homes will be offered to participate in the research. Participants will undergo cognitive and functional assessments that will be carried out on four specific dates. The participants of the Intervention Group will participate in the Feuerstein program using a method of mediated learning while the Control Group will participate in a program of the Adler Institute involving activities aimed at social and emotional development without specific cognitive skill training.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Computerised cognitive training for preventing dementia in people with mild cognitive impairment.
    Gates NJ, Vernooij RW, Di Nisio M, Karim S, et al · · 2019 · cited 97× · PMID 30864747 · DOI 10.1002/14651858.cd012279.pub2
  2. Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life.
    Gates NJ, Rutjes AW, Di Nisio M, Karim S, et al · · 2020 · cited 53× · PMID 32104914 · DOI 10.1002/14651858.cd012277.pub3
  3. Computerised cognitive training for maintaining cognitive function in cognitively healthy people in late life.
    Gates NJ, Rutjes AW, Di Nisio M, Karim S, et al · · 2019 · cited 38× · PMID 30864187 · DOI 10.1002/14651858.cd012277.pub2
  4. Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife.
    Gates NJ, Rutjes AW, Di Nisio M, Karim S, et al · · 2019 · cited 25× · PMID 30864746 · DOI 10.1002/14651858.cd012278.pub2

Verify or expand the search:

Other trials of Feuerstein Program

Trials testing the same drug.

Other recruiting trials for Mild Cognitive Impairment

Currently open trials in the same condition.

Other Rambam Health Care Campus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02774083.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing